MDXHEALTH SA Share Price Today: Live Updates & Key Insights

MDXHEALTH SA share price today is $3.16, up -3.07%. The stock opened at $3.22 against the previous close of $3.26, with an intraday high of $3.25 and low of $3.16.

MDXHEALTH SA Share Price Chart

MDXHEALTH SA

us-stock
To Invest in {{usstockname}}
us-stock

MDXHEALTH SA Share Price Performance

$3.16 -0.0307(-3.07%) MDXH at 23 Mar 2026 02:14 PM Diagnostics & Research
Lowest Today 3.16
Highest Today 3.25
Today’s Open 3.22
Prev. Close 3.26
52 Week High 5.33
52 Week Low 1.36
Day’s Range: Low 3.16 High 3.25
52-Week Range: Low 1.36 High 5.33
1 day return -
1 Week return -5.07
1 month return -10.42
3 month return -7.28
6 month return -31.75
1 year return +119.31
3 year return +14.8
5 year return -73.41
10 year return -

MDXHEALTH SA Institutional Holdings

Hood River Small/Mid Cap Gr CITFounder's 0.57

Hood River Small/Mid-Cap Growth 0.57

Pleiades Small Cap Equity A 0.31

Hood River International Opp Instl 0.17

Perkins Discovery 0.13

Fidelity® NASDAQ Composite Index® 0.01

Rhumbline Advisers 0.00

Marshall Wace Asset Management Ltd 0.00

MDXHEALTH SA Market Status

Strong Buy: 5

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

MDXHEALTH SA Fundamentals

Market Cap 162.31 M

PB Ratio 23.6373

PE Ratio 0.0

Enterprise Value 219.88 M

Total Assets 147.95 M

Volume 84136

MDXHEALTH SA Company Financials

Annual Revenue FY23:63686000 63.7M, FY22:37054000 37.1M, FY21:22239000 22.2M, FY20:18372000 18.4M, FY19:11785000 11.8M

Annual Profit FY23:38482000 38.5M, FY22:19219000 19.2M, FY21:10412000 10.4M, FY20:7849000 7.8M, FY19:-144000 -0.1M

Annual Net worth FY23:-44818000 -44.8M, FY22:-50188000 -50.2M, FY21:-30877000 -30.9M, FY20:-30007000 -30.0M, FY19:-43100000 -43.1M

Quarterly Revenue Q3/2025:27433000 27.4M, Q2/2025:53210000 53.2M, Q1/2025:24292000 24.3M, Q3/2024:23317000 23.3M, Q2/2024:22159000 22.2M

Quarterly Profit Q3/2025:17875000 17.9M, Q2/2025:35134000 35.1M, Q1/2025:15504000 15.5M, Q3/2024:14275000 14.3M, Q2/2024:13286000 13.3M

Quarterly Net worth Q3/2025:-8010000 -8.0M, Q2/2025:-14744000 -14.7M, Q1/2025:-9209000 -9.2M, Q3/2024:-11189000 -11.2M, Q2/2024:-11528000 -11.5M

About MDXHEALTH SA & investment objective

Company Information MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It also offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration with the University of Oxford: the initiation of Genomic Prostate Score (GPS) testing in the landmark UK ProtecT trial (Prostate Testing for Cancer and Treatment). The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Organisation Diagnostics & Research

Employees 312

Industry Diagnostics & Research

CEO Mr. Michael K. McGarrity

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

MDXHEALTH SA FAQs

What is the share price of MDXHEALTH SA today?

The current share price of MDXHEALTH SA is $3.16.

Can I buy MDXHEALTH SA shares in India?

Yes, Indian investors can buy MDXHEALTH SA shares by opening an international trading and demat account with Motilal Oswal.

How to buy MDXHEALTH SA shares in India?

You can easily invest in MDXHEALTH SA shares from India by:

Can I buy fractional shares of MDXHEALTH SA?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of MDXHEALTH SA?

MDXHEALTH SA has a market cap of $162.31 M.

In which sector does MDXHEALTH SA belong?

MDXHEALTH SA operates in the Diagnostics & Research sector.

What documents are required to invest in MDXHEALTH SA stocks?

To invest, you typically need:

What is the PE and PB ratio of MDXHEALTH SA?

The PE ratio of MDXHEALTH SA is N/A and the PB ratio is 23.64.